Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 22:5:16.
doi: 10.1186/s40794-019-0092-x. eCollection 2019.

Imported visceral leishmaniasis and immunosuppression in seven Norwegian patients

Thomas Schwartz  1   2 , Mogens Jensenius  1 , Bjørn Blomberg  3   4 , Cathrine Fladeby  5 , Arild Mæland  1 , Frank O Pettersen  1   6
Affiliations

Imported visceral leishmaniasis and immunosuppression in seven Norwegian patients

Thomas Schwartz et al. Trop Dis Travel Med Vaccines. .

Abstract

Background: Visceral leishmaniasis (VL) is a protozoal disease that may be aggravated by immunosuppression. In recent years, a growing number of patients with chronic diseases use biological treatment. When such immunosuppressed patients travel to endemic areas, they are facing the risk of VL. Increased incidence of leishmaniasis is reported in endemic areas like the Mediterranean basin, an area frequently visited by Norwegian tourists. This may lead to an increased number of patients, many presenting to health personnel unfamiliar with the disease, in their home countries.

Methods: We reviewed the files of seven immunosuppressed patients with VL, admitted to Oslo and Haukeland University Hospitals in Norway in the period 2009-2018.

Results: The patients were 41-83 (median 66) years of age; four had rheumatic disease all of whom used methotrexate; one had advanced HIV infection, one had inflammatory bowel disease and one had myelofibrosis. Leishmania infantum was confirmed in five patients by polymerase chain reaction (PCR) and sequencing. In the remaining two patients, a definite Leishmania species could not be identified. All patients had a history of recent recreational travel to Spain. Most patients underwent extensive diagnostic work-up before diagnosed with VL. All received treatment with liposomal amphotericin B and all were cured; albeit two after re-treatment due to relapse.

Conclusions: Visceral leishmaniasis is a potentially life-threatening but usually treatable condition. It is endemic in Southern Europe, including popular tourist destinations such as the Mediterranean basin. It is relatively unknown to most medical practitioners in non-endemic areas and clinical vigilance is required to identify those who are infected.

Keywords: Autoimmune disease; Immunosuppression; Leishmaniasis; Methotrexate; Rheumatic disease; Travel medicine; Tumor necrosis factor alpha inhibitor.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Amastigotes (yellow arrows) in bone marrow aspirate, with May-Grünwald-Giemsa staining from patient 5, magnified × 40
See this image and copyright information in PMC

References

    1. Ma S. Leishmaniasis. Manson's tropical diseases. 23. 2014. pp. 631–651.
    1. Seaman J, Mercer AJ, Sondorp E. The epidemic of visceral leishmaniasis in western upper Nile, southern Sudan: course and impact from 1984 to 1994. Int J Epidemiol. 1996;25(4):862–871. doi: 10.1093/ije/25.4.862. - DOI - PubMed
    1. Bern C, Maguire JH, Alvar J. Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis. 2008;2(10):e313. doi: 10.1371/journal.pntd.0000313. - DOI - PMC - PubMed
    1. Martin-Sanchez J, Morales-Yuste M, Acedo-Sanchez C, Baron S, Diaz V, Morillas-Marquez F. Canine leishmaniasis in southeastern Spain. Emerg Infect Dis. 2009;15(5):795–798. doi: 10.3201/eid1505.080969. - DOI - PMC - PubMed
    1. Ready PD. Leishmaniasis emergence in Europe. Euro Surveill. 2010;15(10):19505. - PubMed

LinkOut - more resources